Industry: Medical Devices & Consumables
Published Date: 2026-06-16
Pages: 154 Pages
Report ld: 6743770
Request Sample
Customized Report
Tumor Ablation Needle Market Size(US$)

CAGR 2026-2032
8.5%
Market Size,2032
USD 2,282
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Tumor Ablation Needle was estimated to be worth US$ 1299 million in 2025 and is projected to reach US$ 2282 million, growing at a CAGR of 8.5% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Tumor Ablation Needle cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report provides a comprehensive view of the global market for Tumor Ablation Needle, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Tumor Ablation Needle market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Tumor Ablation Needle.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Tumor Ablation Needle manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Tumor Ablation Needle sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Tumor Ablation Needle sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Tumor Ablation Needle Product Introduction
1.2 Global Tumor Ablation Needle Market Size Forecast
1.2.1 Global Tumor Ablation Needle Sales Value (2021–2032)
1.2.2 Global Tumor Ablation Needle Sales Volume (2021–2032)
1.2.3 Global Tumor Ablation Needle Sales Price (2021–2032)
1.3 Tumor Ablation Needle Market Trends & Drivers
1.3.1 Tumor Ablation Needle Industry Trends
1.3.2 Tumor Ablation Needle Market Drivers & Opportunities
1.3.3 Tumor Ablation Needle Market Challenges
1.3.4 Tumor Ablation Needle Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tumor Ablation Needle Players Revenue Ranking (2025)
2.2 Global Tumor Ablation Needle Revenue by Company (2021–2026)
2.3 Global Tumor Ablation Needle Sales Volume Ranking of Players (2025)
2.4 Global Tumor Ablation Needle Sales Volume by Company (2021–2026)
2.5 Global Tumor Ablation Needle Average Price by Company (2021–2026)
2.6 Key Manufacturers Tumor Ablation Needle Manufacturing Base and Headquarters
2.7 Key Manufacturers Tumor Ablation Needle Product Offerings
2.8 Key Manufacturers Start of Mass Production of Tumor Ablation Needle
2.9 Tumor Ablation Needle Market Competitive Analysis
2.9.1 Tumor Ablation Needle Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Tumor Ablation Needle Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tumor Ablation Needle revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Tumor Ablation Needle Market Classification
3.1 Introduction by Type
3.1.1 Microwave Ablation Needle
3.1.2 Radiofrequency Ablation Needle
3.1.3 Cryoablation Needle
3.1.4 Nanoknife Ablation Needle
3.1.5 Global Tumor Ablation Needle Sales Value by Type
3.1.5.1 Global Tumor Ablation Needle Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Tumor Ablation Needle Sales Value, by Type (2021–2032)
3.1.5.3 Global Tumor Ablation Needle Sales Value, by Type (%), 2021–2032
3.1.6 Global Tumor Ablation Needle Sales Volume by Type
3.1.6.1 Global Tumor Ablation Needle Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Tumor Ablation Needle Sales Volume, by Type (2021–2032)
3.1.6.3 Global Tumor Ablation Needle Sales Volume, by Type (%), 2021–2032
3.1.7 Global Tumor Ablation Needle Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Ambulatory Surgery Center
4.1.3 Other
4.2 Global Tumor Ablation Needle Sales Value by Application
4.2.1 Global Tumor Ablation Needle Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Tumor Ablation Needle Sales Value, by Application (2021–2032)
4.2.3 Global Tumor Ablation Needle Sales Value, by Application (%), 2021–2032
4.3 Global Tumor Ablation Needle Sales Volume by Application
4.3.1 Global Tumor Ablation Needle Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Tumor Ablation Needle Sales Volume, by Application (2021–2032)
4.3.3 Global Tumor Ablation Needle Sales Volume, by Application (%), 2021–2032
4.4 Global Tumor Ablation Needle Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Tumor Ablation Needle Sales Value by Region
5.1.1 Global Tumor Ablation Needle Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Tumor Ablation Needle Sales Value by Region (2021–2026)
5.1.3 Global Tumor Ablation Needle Sales Value by Region (2027–2032)
5.1.4 Global Tumor Ablation Needle Sales Value by Region (%), 2021–2032
5.2 Global Tumor Ablation Needle Sales Volume by Region
5.2.1 Global Tumor Ablation Needle Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Tumor Ablation Needle Sales Volume by Region (2021–2026)
5.2.3 Global Tumor Ablation Needle Sales Volume by Region (2027–2032)
5.2.4 Global Tumor Ablation Needle Sales Volume by Region (%), 2021–2032
5.3 Global Tumor Ablation Needle Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Tumor Ablation Needle Sales Value, 2021–2032
5.4.2 North America Tumor Ablation Needle Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Tumor Ablation Needle Sales Value, 2021–2032
5.5.2 Europe Tumor Ablation Needle Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Tumor Ablation Needle Sales Value, 2021–2032
5.6.2 Asia Pacific Tumor Ablation Needle Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Tumor Ablation Needle Sales Value, 2021–2032
5.7.2 South America Tumor Ablation Needle Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tumor Ablation Needle Sales Value, 2021–2032
5.8.2 Middle East & Africa Tumor Ablation Needle Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tumor Ablation Needle Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Tumor Ablation Needle Sales Value and Sales Volume
6.2.1 Key Countries/Regions Tumor Ablation Needle Sales Value, 2021–2032
6.2.2 Key Countries/Regions Tumor Ablation Needle Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Tumor Ablation Needle Sales Value, 2021–2032
6.3.2 United States Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Tumor Ablation Needle Sales Value, 2021–2032
6.4.2 Europe Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Tumor Ablation Needle Sales Value, 2021–2032
6.5.2 China Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.5.3 China Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Tumor Ablation Needle Sales Value, 2021–2032
6.6.2 Japan Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Tumor Ablation Needle Sales Value, 2021–2032
6.7.2 South Korea Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Tumor Ablation Needle Sales Value, 2021–2032
6.8.2 Southeast Asia Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Tumor Ablation Needle Sales Value, 2021–2032
6.9.2 India Tumor Ablation Needle Sales Value by Type (%), 2025 vs 2032
6.9.3 India Tumor Ablation Needle Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Angiodynamics
7.1.1 Angiodynamics Company Information
7.1.2 Angiodynamics Introduction and Business Overview
7.1.3 Angiodynamics Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Angiodynamics Tumor Ablation Needle Product Offerings
7.1.5 Angiodynamics Recent Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Introduction and Business Overview
7.2.3 Boston Scientific Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Boston Scientific Tumor Ablation Needle Product Offerings
7.2.5 Boston Scientific Recent Developments
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Medtronic Tumor Ablation Needle Product Offerings
7.3.5 Medtronic Recent Developments
7.4 Smith and Nephew
7.4.1 Smith and Nephew Company Information
7.4.2 Smith and Nephew Introduction and Business Overview
7.4.3 Smith and Nephew Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Smith and Nephew Tumor Ablation Needle Product Offerings
7.4.5 Smith and Nephew Recent Developments
7.5 Starmed
7.5.1 Starmed Company Information
7.5.2 Starmed Introduction and Business Overview
7.5.3 Starmed Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Starmed Tumor Ablation Needle Product Offerings
7.5.5 Starmed Recent Developments
7.6 Siemens
7.6.1 Siemens Company Information
7.6.2 Siemens Introduction and Business Overview
7.6.3 Siemens Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Siemens Tumor Ablation Needle Product Offerings
7.6.5 Siemens Recent Developments
7.7 PAJUNK
7.7.1 PAJUNK Company Information
7.7.2 PAJUNK Introduction and Business Overview
7.7.3 PAJUNK Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 PAJUNK Tumor Ablation Needle Product Offerings
7.7.5 PAJUNK Recent Developments
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Information
7.8.2 Johnson and Johnson Introduction and Business Overview
7.8.3 Johnson and Johnson Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Johnson and Johnson Tumor Ablation Needle Product Offerings
7.8.5 Johnson and Johnson Recent Developments
7.9 Med-Italia Biomedica
7.9.1 Med-Italia Biomedica Company Information
7.9.2 Med-Italia Biomedica Introduction and Business Overview
7.9.3 Med-Italia Biomedica Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Med-Italia Biomedica Tumor Ablation Needle Product Offerings
7.9.5 Med-Italia Biomedica Recent Developments
7.10 Thermedical
7.10.1 Thermedical Company Information
7.10.2 Thermedical Introduction and Business Overview
7.10.3 Thermedical Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Thermedical Tumor Ablation Needle Product Offerings
7.10.5 Thermedical Recent Developments
7.11 Erbe Elektromedizin GmbH
7.11.1 Erbe Elektromedizin GmbH Company Information
7.11.2 Erbe Elektromedizin GmbH Introduction and Business Overview
7.11.3 Erbe Elektromedizin GmbH Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Erbe Elektromedizin GmbH Tumor Ablation Needle Product Offerings
7.11.5 Erbe Elektromedizin GmbH Recent Developments
7.12 Betters Medical
7.12.1 Betters Medical Company Information
7.12.2 Betters Medical Introduction and Business Overview
7.12.3 Betters Medical Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Betters Medical Tumor Ablation Needle Product Offerings
7.12.5 Betters Medical Recent Developments
7.13 Nanjing ECO Microwave System
7.13.1 Nanjing ECO Microwave System Company Information
7.13.2 Nanjing ECO Microwave System Introduction and Business Overview
7.13.3 Nanjing ECO Microwave System Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Nanjing ECO Microwave System Tumor Ablation Needle Product Offerings
7.13.5 Nanjing ECO Microwave System Recent Developments
7.14 Nanjing MICRO-TECH
7.14.1 Nanjing MICRO-TECH Company Information
7.14.2 Nanjing MICRO-TECH Introduction and Business Overview
7.14.3 Nanjing MICRO-TECH Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Nanjing MICRO-TECH Tumor Ablation Needle Product Offerings
7.14.5 Nanjing MICRO-TECH Recent Developments
7.15 VISON Medical
7.15.1 VISON Medical Company Information
7.15.2 VISON Medical Introduction and Business Overview
7.15.3 VISON Medical Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 VISON Medical Tumor Ablation Needle Product Offerings
7.15.5 VISON Medical Recent Developments
7.16 Nanjing Greatwall Wisemedical Tech
7.16.1 Nanjing Greatwall Wisemedical Tech Company Information
7.16.2 Nanjing Greatwall Wisemedical Tech Introduction and Business Overview
7.16.3 Nanjing Greatwall Wisemedical Tech Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Nanjing Greatwall Wisemedical Tech Tumor Ablation Needle Product Offerings
7.16.5 Nanjing Greatwall Wisemedical Tech Recent Developments
7.17 Angel Medical Science and Technology
7.17.1 Angel Medical Science and Technology Company Information
7.17.2 Angel Medical Science and Technology Introduction and Business Overview
7.17.3 Angel Medical Science and Technology Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Angel Medical Science and Technology Tumor Ablation Needle Product Offerings
7.17.5 Angel Medical Science and Technology Recent Developments
7.18 Leader Electronics
7.18.1 Leader Electronics Company Information
7.18.2 Leader Electronics Introduction and Business Overview
7.18.3 Leader Electronics Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Leader Electronics Tumor Ablation Needle Product Offerings
7.18.5 Leader Electronics Recent Developments
7.19 Zhuhai Hokai Medical
7.19.1 Zhuhai Hokai Medical Company Information
7.19.2 Zhuhai Hokai Medical Introduction and Business Overview
7.19.3 Zhuhai Hokai Medical Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Zhuhai Hokai Medical Tumor Ablation Needle Product Offerings
7.19.5 Zhuhai Hokai Medical Recent Developments
7.20 MedSphere International
7.20.1 MedSphere International Company Information
7.20.2 MedSphere International Introduction and Business Overview
7.20.3 MedSphere International Tumor Ablation Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 MedSphere International Tumor Ablation Needle Product Offerings
7.20.5 MedSphere International Recent Developments
8 Industry Chain Analysis
8.1 Tumor Ablation Needle Industrial Chain
8.2 Tumor Ablation Needle Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Tumor Ablation Needle Sales Model
8.5.2 Sales Channels
8.5.3 Tumor Ablation Needle Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Tumor Ablation Needle market was valued at US$ 1299 million in 2025 and is anticipated to reach US$ 2282 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 137
USD 2900.00
(Single User License)
The global Tumor Ablation Needle market size was US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 106
USD 4250.00
(Single User License)
The global Tumor Ablation Needle market is projected to grow from US$ 1207 million in 2024 to US$ 2119 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 176
USD 4900.00
(Single User License)
The global market for Tumor Ablation Needle was valued at US$ 1207 million in the year 2024 and is projected to reach a revised size of US$ 2119 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published Date: 2025-01-16
Pages: 107
USD 2900.00
(Single User License)
The global market for Tumor Ablation Needle was estimated to be worth US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 150
USD 3950.00
(Single User License)
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-04-12
Pages: 128
USD 4900.00
(Single User License)
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-01-17
Pages: 113
USD 2900.00
(Single User License)
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published Date: 2024-01-10
Pages: 174
USD 3950.00
(Single User License)
The global Tumor Ablation Needle market was valued at US$ 1299 million in 2025 and is anticipated to reach US$ 2282 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 137
The global Tumor Ablation Needle market size was US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 106
The global Tumor Ablation Needle market is projected to grow from US$ 1207 million in 2024 to US$ 2119 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 176
The global market for Tumor Ablation Needle was valued at US$ 1207 million in the year 2024 and is projected to reach a revised size of US$ 2119 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published: 2025-01-16
Pages: 107
The global market for Tumor Ablation Needle was estimated to be worth US$ 1207 million in 2024 and is forecast to a readjusted size of US$ 2119 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 150
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-04-12
Pages: 128
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-01-17
Pages: 113
Tumor ablation needles include microwave ablation needles, radiofrequency ablation needles, cryoablation needles, nano-knife ablation needles, etc.
Published: 2024-01-10
Pages: 174
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now